Please use this identifier to cite or link to this item:
|Title:||Regulators of mammalian Hippo pathway in cancer||Authors:||Liu, A.M.
|Issue Date:||Dec-2012||Citation:||Liu, A.M., Wong, K.-F., Jiang, X., Qiao, Y., Luk, J.M. (2012-12). Regulators of mammalian Hippo pathway in cancer. Biochimica et Biophysica Acta - Reviews on Cancer 1826 (2) : 357-364. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbcan.2012.05.006||Abstract:||Hippo pathway, originally discovered in Drosophila, is responsible for organ size control. The pathway is conserved in mammals and has a significant role in restraining cancer development. Regulating the Hippo pathway thus represents a potential therapeutic approach to treat cancer, which however requires deep understanding of the targeted pathway. Despite our limited knowledge on the pathway, there are increasing discoveries of new molecules that regulate and modulate the Hippo downstream signaling particularly in various solid malignancies, from extracellular stimuli or via pathway crosstalk. Herein, we discuss the roles of newly identified and key regulators that connect with core components (MST1/2, LATS1/2, SAV1, and MOB1) and downstream effector (YAP) in the Hippo pathway having an important role in cancer development and progression. Understanding of the mammalian Hippo pathway regulation may shed new insights to allow us selecting the right oncogenic targets and designing effective drugs for cancer treatments. © 2012 Elsevier B.V.||Source Title:||Biochimica et Biophysica Acta - Reviews on Cancer||URI:||http://scholarbank.nus.edu.sg/handle/10635/108683||ISSN:||0304419X||DOI:||10.1016/j.bbcan.2012.05.006|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 3, 2020
WEB OF SCIENCETM
checked on Jun 25, 2020
checked on Jun 27, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.